BioPact’s innovative drug delivery platform, Medical Grade Molecular Rebar (MGMR™), comprises discrete, individualized, pure, length-controlled, surface-functionalized carbon nanotubes (CNT). By utilizing our patented technology, drug developers can solve challenges in many arenas such as: controlled release, targeted delivery, transdermal delivery, toxicity, physiological instability, intracellular delivery, or crossing the blood-brain barrier. The unique properties of these tubes overcome the limitations of traditional CNT which are impure, tangled bundles of carbon. MGMR can be internally loaded with large and/or small molecules, regardless of chemistries, while the exterior of the tube is available for functionalization with bioactive agents to create a targeted drug delivery system.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.